37 CFR § 1.823 — Requirements for content of a “Sequence Listing” (MPEP Index) – BlueIron IP
37 CFR § 1.823 Requirements for content of a “Sequence Listing”
This page consolidates MPEP guidance interpreting 37 CFR § 1.823, including 52 rules from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only, it is not legal advice.
Official MPEP § 1.823 — Requirements for content of a “Sequence Listing”
Source: USPTOLast Modified: 10/30/2024 08:50:22
1.823 Requirements for content of a “Sequence Listing” part of the specification.
[Editor Note: This rule is applicable to applications containing a nucleotide and/or amino acid sequence filed prior to July 1, 2022. See §§ 1.831 through 1.835 for rules applicable on or after July 1, 2022.]
- (a) The “Sequence Listing” must comply with
the following:
- (1) The order and presentation of the items of information in the “Sequence Listing” shall conform to the arrangement in appendix G to this subpart. The submission of those items of information designated with an “M” is mandatory. The submission of those items of information designated with an “O” is optional.
- (2) Each item of information shall begin on a new line, with the numeric identifier enclosed in angle brackets, as shown in appendix G to this subpart.
- (3) Set forth numeric identifiers <110> through <170> at the beginning of the “Sequence Listing.”
- (4) Include each disclosed nucleotide and/or amino acid sequence, as defined in § 1.821(a) .
- (5) Assign a separate sequence identifier to each sequence, beginning with 1 and increasing sequentially by integers, and include the sequence identifier in numeric identifier <210>.
- (6) Use the code “000” in place of the sequence where no sequence is present for a sequence identifier.
- (7) Include the total number of SEQ ID NOs in numeric identifier <160> , as defined in appendix G to this subpart, whether followed by a sequence or by the code “000.”
- (8) Must not contain more than 74 characters per line.
- (b)
- (1) Unless paragraph (b)(2) of this section
applies, if the “Sequence Listing” required by §
1.821(c)
is submitted
as an ASCII plain text file via the USPTO patent electronic
filing system or on a read-only optical disc, in compliance
with §
1.52(e)
, then the
specification must contain a statement in a separate
paragraph (see §
1.77(b)(5)
) that incorporates by
reference the material in the ASCII plain text file
identifying:
- (i) The name of the file;
- (ii) The date of creation; and
- (iii) The size of the file in bytes.
- (2) If the “Sequence Listing” required by § 1.821(c) is submitted as an ASCII plain text file via the USPTO patent electronic filing system or on a read-only optical disc, in compliance with § 1.52(e) for an international application during the international stage, then incorporation by reference of the material in the ASCII plain text file is not required.
- (3) A “Sequence Listing” required by
§
1.821(c)
that is
submitted as a PDF file (§
1.821(c)(2)
) via the USPTO patent
electronic filing system or on physical sheets of paper (§
1.821(c)(3)
), setting forth the
nucleotide and/or amino acid sequence and associated
information in accordance with paragraph (a) of this section:
- (i) Must begin on a new page;
- (ii) Must be titled “Sequence Listing”;
- (iii) Must not include material other than the “Sequence Listing” itself;
- (iv) Must have sheets containing no more than 66 lines, with each line containing no more than 74 characters;
- (v) Should have sheets numbered independently of the numbering of the remainder of the application; and
- (vi) Should use a fixed-width font exclusively throughout.
- (1) Unless paragraph (b)(2) of this section
applies, if the “Sequence Listing” required by §
1.821(c)
is submitted
as an ASCII plain text file via the USPTO patent electronic
filing system or on a read-only optical disc, in compliance
with §
1.52(e)
, then the
specification must contain a statement in a separate
paragraph (see §
1.77(b)(5)
) that incorporates by
reference the material in the ASCII plain text file
identifying:
[Added, 55 FR 18230, May 1, 1990, effective Oct. 1, 1990; revised, 63 FR 29620, June 1, 1998, effective July 1, 1998; heading and para. (a) revised, 65 FR 54604, Sept. 8, 2000, effective Sept. 8, 2000 (effective date corrected, 65 FR 78958, Dec. 18, 2000); para. (a)(1) revised, 68 FR 38611, June 30, 2003, effective July 30, 2003; revised, 86 FR 57035, Oct. 14, 2021, effective Nov. 15, 2021]
- Access Records
- Access International
- Pct
- Pct Amendments Article 19
- Pct Description Claims
- Pct Filing
-
- Pct National Stage Entry
- Pct Publication
- Sequence Listing
- Supplemental Examination
-